在2026年2月4日发布的早期试验结果中,在BC维多利亚的一种新型前列腺癌治疗方法缩小了瘤并改善了生物标志物. A new prostate cancer treatment in Victoria, BC, shrank tumors and improved biomarkers in early trial results released Feb. 4, 2026.

根据2026年2月4日公布的初步调查结果,在不列颠哥伦比亚省维多利亚州进行的临床试验显示,治疗前列腺癌取得了可喜的成果,参与者的肿瘤体积大幅下降,生物标记水平有所提高。 A clinical trial in Victoria, British Columbia, has shown promising results in treating prostate cancer, with participants experiencing significant reductions in tumor size and improved biomarker levels, according to preliminary findings released on February 4, 2026. 这项研究涉及一项新的有针对性的治疗,目前正在进行中,如果进一步的成果仍然积极,可能会导致更广泛的临床使用。 The study, which involved a new targeted therapy, is ongoing and may lead to broader clinical use if further results remain positive.